This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Queen's University at Kingston. Active years: 1998-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2006
Title: Innovations by Inventor Brian M Bennett
Introduction
Brian M Bennett is a prominent inventor based in Kingston, CA, recognized for his contributions to the field of pain management and neurological health. With a total of seven patents under his name, Bennett has made significant strides in developing therapeutic compounds that address critical health issues.
Latest Patents
Among his notable inventions, Bennett's latest patents include methods and compositions for mitigating pain. These patents encompass therapeutic compounds designed to treat pain, reduce inflammation, induce analgesia, and effect sedation in subjects. The use of nitrate esters as therapeutic agents represents a breakthrough in the pharmaceutical industry. Additionally, he has developed compounds and methodologies aimed at mitigating neurodegeneration and enhancing cognitive abilities through the administration of nitrate esters.
Career Highlights
Brian M Bennett is affiliated with Queen's University at Kingston, where he is engaged in pioneering research. His work has not only expanded the existing knowledge base in pharmacology but has also paved the way for innovative treatments in medicine.
Collaborations
Bennett collaborates with esteemed colleagues, including James N Reynolds and Khem Jhamandas, contributing to a rich exchange of ideas and expertise in the development of novel pharmaceutical solutions. This collaborative environment enhances the scope and impact of their collective research endeavors.
Conclusion
As an inventor, Brian M Bennett continues to push the boundaries of science and technology. His patents reflect a commitment to improving health outcomes and advancing the field of therapeutics. Through his contributions, Bennett remains a valuable asset to both the academic community and the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
